FDA has approved a new Alzheimer’s drug despite mixed trial results | Science News

FDA has approved a new Alzheimer’s drug despite mixed trial results | Science News: A new Alzheimer's treatment slows progression of the disease, the drug’s developers say. But some researchers question its effectiveness.

Comments

Popular posts from this blog

My current Facebook diatribe

» Dear Helen: From One American Lebanese Journalist To another… - Big Journalism